Detail akcie China Pharm online

Business Summary: CSPC Pharmaceutical Group Ltd is an investment holding company primarily engaged in the manufacture and sale of pharmaceutical products. The Company operates its business through three segments. The Finished Drugs segment in engaged in the research and development, manufacture and sale of pharmaceutical products and licensing business. The Bulk Products segment is engaged in the manufacture and sale of vitamin C, and antibiotic products in bulk powder form. The Functional Food and Others segment is engaged in the manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. The Company’s product therapeutic areas include nervous system, oncology, anti-infectives, cardiovascular, respiratory system, digestion and metabolism and others. The Company conducts its business in the domestic and overseas markets.
Financial Summary: BRIEF: For the six months ended 30 June 2024, CSPC Pharmaceutical Group Ltd revenues increased 1% to RMB16.28B. Net income increased 2% to RMB3.02B. Revenues reflect Finished Drugs segment increase of 5% to RMB13.55B. Net income benefited from Finished Drugs segment income increase of 9% to RMB3.49B, Antibiotics segment income increase from RMB71.4M to RMB186.2M, Vitamin C segment income remaining flat at RMB67.6M.